White House sets a national policy requiring federally funded labs to buy synthetic DNA only from certified suppliers
The White House · Policy memorandum
Read the source (opens in a new tab)- What happened
- National Security Advisor Marco Rubio and OSTP Director Michael Kratsios issued a memorandum (NSTM-6) on November 5, 2026 setting a National Policy for Nucleic Acid Synthesis Screening under Executive Order 14292.
- Key points
- It conditions federal life-sciences funding on buying synthetic nucleic acids and benchtop synthesis equipment only from certified suppliers that verify customers and the sequences ordered.
- It replaces the 2024 screening framework, saying existing guidance "relied on self-attestation rather than independent verification" that let some firms bypass safeguards.
- It sets deadlines: NIST screening standards within 90 days, an HHS list of adherent suppliers within 160 days, certified-supplier procurement within 250 days and benchtop equipment within 340 days.
- It ties screening to AI, saying controls must keep pace with risks "including those from SI uplift" and will shift from list-based to risk-based screening.
- Evidence
- White House policy memorandum. It conditions federal funding and sets deadlines; it directs agency action rather than creating new law, and applies to recipients of federal funds.